David serves as Director of Investor Relations in Toronto, breaking new ground for OurCrowd and startup investing in Canada. Prior to OurCrowd, David was a venture capitalist, angel investor and top ranked equity analyst at Mackie Research, CIBC, and Desjardins. As the Managing Director of Terracap Ventures, David developed the firm's overall corporate strategy. David also served as Head of the Technology Group for Mackie Research Capital in the Equity Research department covering Software & Media sectors. David was consistently ranked as a leading technology analyst (software) in Canada, and prior to joining Mackie Research Capital worked at leading financial institutions, including Desjardins, CIBC World Markets, and First Marathon. David ‘s operational experience includes roles as CFO at several startups including Cavet and Beam Networks. David sits on the Advisory Board of the Canadian Innovation Exchange and also serves as an Advisor to Charity Bids. Additionally, David was a board Director at Sarda Technologies and Helix Medical Systems and recently joined The Next 36 as an advisor.

David Shore
Director of Investor Relations, Canada

If you are interested in learning more about TIGER 21, please complete the contact form and you will receive a copy of our most recent Asset Allocation Report.